Literature DB >> 6933488

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.

J M Drazen, K F Austen, R A Lewis, D A Clark, G Goto, A Marfat, E J Corey.   

Abstract

The pharmacologic activities of leukotrienes C-1 and D(LTC-1 and LTD), constituents of slow reacting substance of anaphylaxis (SRS-A), were evaluated in vitro on airway contractile tissues and in vivo on pulmonary mechanical function, mean systemic arterial pressure, and cutaneous microcirculation. In vitro both LTC-1 and LTD were potent and selective peripheral airway agonists, being more active than histamine; furthermore, LTD was active on peripheral airways at concentrations 1/100th those of LTC-1. The concentration-effect relationship for LTD and the profile of antagonism by FPL 55712 are consistent with the activity of this molecule at two separate peripheral airway receptors. In vivo, LTC-1 and LTD were nearly equally active in their effects on pulmonary mechanics, and the pattern of alterations was consistent with the predominant site of action being in the lung periphery. Furthermore, both agents had a direct systemic arterial hypotensive effect and were vasoactive on the cutaneous microcirculation. Thus, these compounds are likely to be major mediators of the pathologic alterations in immediate type hypersensitivity reactions in which peripheral airway constriction and hypotension are prominent features.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933488      PMCID: PMC349833          DOI: 10.1073/pnas.77.7.4354

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

3.  Occurrence of an unidentified substance during anaphylactic shock in cavy lung.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1953-04-28       Impact factor: 5.182

4.  Bronchodilator activity of dimaprit in the guinea pig in vitro and in vivo.

Authors:  J M Drazen; M W Schneider; C S Venugopalan
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

5.  Structure of leukotriene C. Identification of the amino acid part.

Authors:  S Hammarström; R C Murphy; B Samuelsson; D A Clark; C Mioskowski; E J Corey
Journal:  Biochem Biophys Res Commun       Date:  1979-12-28       Impact factor: 3.575

6.  Pulmonary response to antigen infusion in the sensitized guinea pig: modification by atropine.

Authors:  J M Drazen; K F Austen
Journal:  J Appl Physiol       Date:  1975-12       Impact factor: 3.531

7.  Lung mechanics following antigen challenge of Ascaris suum-sensitive rhesus monkeys.

Authors:  P D Pare; M C Michound; J C Hogg
Journal:  J Appl Physiol       Date:  1976-11       Impact factor: 3.531

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

Authors:  R C Murphy; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

10.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  98 in total

Review 1.  The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Authors:  R L Bell; R R Harris
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Leukotriene receptors.

Authors:  S E Dahlén
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 3.  The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.

Authors:  R A Simon
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 4.  Regulation of expression of the 5-lipoxygenase pathway.

Authors:  T D Bigby
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.

Authors:  Y Nakamura; M Hoshino; J J Sim; K Ishii; K Hosaka; T Sakamoto
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 6.  Anti-leukotrienes in asthma: yet to arrive.

Authors:  G Gupta
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

7.  Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.

Authors:  Laurence Walch; Xavier Norel; Magnus Bäck; Jean-Pierre Gascard; Sven-Erik Dahlén; Charles Brink
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 8.  Leukotriene receptors as potential therapeutic targets.

Authors:  Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

9.  Mediators of arachidonic acid-induced contractions of indomethacin-treated guinea-pig airways: leukotrienes C4 and D4.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

10.  Lung responsiveness to antigen in sensitised mice of different strains.

Authors:  C Zuany-Amorim; M Pretolani; D Leduc; R Cordeiro; B B Vargaftig
Journal:  Agents Actions       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.